effects [qlco]
Lipid [lipd]
lowering [spco]
Hormone replacement therapy [topp]
Serum lipids NOS [lbpr]
Lipoproteins [aapp, bacs]
Overweight [sosy]
postmenopausal [tmco]
Women [popg]
elevated triglycerides [fndg]
Cardiovascular disease [dsyn]
Leading [tmco]
Women [popg]
Menopause [phsf]
Essence [orch]
risk factors [qnco]
Cardiovascular disease [dsyn]
Women [popg]
Men [popg]
serum lipid [lbpr]
perturbation [ftcn]
effects [qlco]
Estrogens [horm, phsu, strd]
Hormone replacement therapy [topp]
Lipid Metabolism [moft]
Evaluation [ftcn]
Combined [qlco]
Lipid lowering drug [phsu]
Study Design [resa]
postmenopausal [tmco]
Women [popg]
Study [mnob]
Open [spco]
Study [mnob]
months [tmco]
Subject [grup]
Outpatient Clinics [hcro, mnob]
rural area [spco]
Sweden [geoa]
Inclusive [ftcn]
criteria [inpr]
Mass [fndg]
Index [inpr]
serum triglycerides [lbpr]
mmol/L [qnco]
participants [popg]
months [tmco]
Post-Menopause [orgf]
Concomitant [tmco]
Follicle Stimulating Hormone [aapp, horm, phsu]
IU/L [qnco]
Inclusion [qlco]
Study [mnob]
Patients [podg]
Adhere [fndg]
low fat [inpr]
Diet [food]
3 Months [tmco]
Group [idcn]
intervention [hlca]
Group [idcn]
Hormone replacement therapy [topp]
Group [idcn]
Group [idcn]
GIVEN [cnce]
Gemfibrozil 600 MG [clnd]
Orally [spco]
Twice daily [tmco]
Hormone replacement therapy [topp]
Group [idcn]
Received [qlco]
mg% [qnco]
Estradiol [horm, phsu, strd]
Combination [qlco]
mg% [qnco]
Norethisterone acetate [horm, phsu, strd]
LIS [moft]
Continuous [idcn]
Combined therapy [topp]
Daily [tmco]
3 Months [tmco]
Group [idcn]
Added [ftcn]
Hormone replacement therapy [topp]
Group [idcn]
Regimen [topp]
Patients [podg]
Hormone replacement therapy [topp]
Group [idcn]
Added [ftcn]
Gemfibrosil [lipd, phsu]
participants [popg]
Received [qlco]
regimens [inpr]
Combined [qlco]
Last [qlco]
months [tmco]
Study [mnob]
serum cholesterol [lbpr]
Markedly [qlco]
Decreased [qnco]
Group [idcn]
months [tmco]
Single [popg]
treatment [ftcn]
P NOS [aapp, imft]
Decrease [qlco]
reflected [menp]
reduction [npop]
Calculated [ftcn]
Low Density Lipoprotein Cholesterol [bacs, strd]
P NOS [aapp, imft]
High Density Lipoprotein Cholesterol [bacs, lipd]
Reduced [qlco]
Hormone replacement therapy [topp]
Group [idcn]
P NOS [aapp, imft]
Increased [qnco]
P NOS [aapp, imft]
Group [idcn]
Triglycerides [bacs, lipd]
Decreased [qnco]
Treatments [topp]
Marked [qlco]
Group [idcn]
P NOS [aapp, imft]
Hormone replacement therapy [topp]
Group [idcn]
P NOS [aapp, imft]
months [tmco]
reduction [npop]
Group [idcn]
Additive [qlco]
encounter [hlca]
Group [idcn]
effects [qlco]
Gemfibrosil [lipd, phsu]
Cholesterol [bacs, strd]
Triglyceride level [lbtr]
Superior [spco]
Continuous [idcn]
Combined [qlco]
Hormone replacement therapy [topp]
Group [idcn]
Overweight [sosy]
Women [popg]
elevated triglycerides [fndg]
Combination [qlco]
Drugs [phsu]
Additional [ftcn]
Benefit [qnco]
Concern [idcn]
Routine [qlco]
serum lipid [lbpr]
Lipoprotein [aapp, bacs]
Profile [lbpr]
Science [ocdi]
Ireland [geoa]
LTD [ortf]
Reserve [acty]
